Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm

Ignasi Garcia-Olivé, Jose Sanz-Santos, Carmen Centeno, Felipe Andreo, Aida Muñoz-Ferrer, Pere Serra, Jaume Sampere, Josep Maria Michavila, Jordi Muchart, Juan Ruiz Manzano

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)


Purpose To describe experience with bronchial artery embolization (BAE) in a cohort of patients with cancer. Materials and Methods All consecutive patients with cancer and at least one episode of hemoptysis that required BAE during a 14-year period were included in this observational retrospective review. The endpoints of the study were immediate success, recurrence of hemoptysis, mortality resulting from hemoptysis, and all-cause mortality. Results Immediate control of bleeding was achieved in 31 of 40 patients (77.5%). Recurrence requiring BAE occurred in eight patients (20%). Cumulative hemoptysis control rate was 0.90 (95% confidence interval [CI], 0.80-1.0) at 1 month and 0.65 (95% CI, 0.44-0.86) at 6 months. Probability of survival was 0.75 (95% CI, 0.62-0.88) at 1 month, 0.42 (95% CI, 0.27-0.57) at 6 months, 0.36 (95% CI, 0.21-0.51) at 12 months, and 0.08 (95% CI, 0.0-0.18) at 3 years. Conclusions BAE is an effective and safe technique in the treatment of hemoptysis in patients with cancer. Nevertheless, mortality resulting from hemoptysis and recurrence rate are high among these patients secondary to progression of the underlying disease. © 2014 SIR.
Original languageEnglish
Pages (from-to)221-228
JournalJournal of Vascular and Interventional Radiology
Issue number2
Publication statusPublished - 1 Feb 2014


Dive into the research topics of 'Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm'. Together they form a unique fingerprint.

Cite this